| scholarly article | Q13442814 |
| P2093 | author name string | McDonnell PJ | |
| P2860 | cites work | Steroids, the eye, and general practitioners | Q34286154 |
| Use of steroid eye drops in general practice | Q34286229 | ||
| The red eye: a general practice survey | Q35236065 | ||
| Eye disease at a community health centre | Q41878874 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 733-736 | |
| P577 | publication date | 1988-10-01 | |
| P1433 | published in | British Journal of Ophthalmology | Q13443571 |
| P1476 | title | How do general practitioners manage eye disease in the community? | |
| P478 | volume | 72 |
| Q39937172 | A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness |
| Q24673012 | A prospective study of cost, patient satisfaction, and outcome of treatment of chalazion by medical and nursing staff |
| Q42557666 | A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice |
| Q33648401 | A survey of the initial referral of children to an ophthalmology department |
| Q40100655 | A survey of the scope of therapeutic practice by UK optometrists and their attitudes to an extended prescribing role |
| Q34095093 | Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis |
| Q24200694 | Antibiotics versus placebo for acute bacterial conjunctivitis |
| Q24246448 | Antibiotics versus placebo for acute bacterial conjunctivitis |
| Q36561021 | Bacterial conjunctivitis in pediatrics and primary care |
| Q38021408 | Besifloxacin ophthalmic suspension, 0.6%: a novel topical fluoroquinolone for bacterial conjunctivitis |
| Q46579471 | Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial |
| Q34053502 | Detection and prevention of treatable visual failure in general practice: room for improvement? |
| Q90193694 | Disparate Entry of Adenoviruses Dictates Differential Innate Immune Responses on the Ocular Surface |
| Q33299030 | Do general practitioners adhere to the guideline on infectious conjunctivitis? Results of the Second Dutch National Survey of General Practice |
| Q40728889 | Effectiveness, tolerability and safety of azithromycin 1% in DuraSite for acute bacterial conjunctivitis |
| Q33659381 | Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis |
| Q36087879 | Efficacy of topical immunoglobulins against experimental adenoviral ocular infection |
| Q61896762 | Evaluation of eLearning for the teaching of undergraduate ophthalmology at medical school: a randomised controlled crossover study |
| Q51107247 | General practitioner registrars' opinions of general practice training in ophthalmology: a questionnaire survey in the northern region. |
| Q42025873 | General practitioners' confidence in diagnosing and managing eye conditions: a survey in south Devon |
| Q74216935 | How effective is undergraduate and postgraduate teaching in ophthalmology? |
| Q33393254 | Major age group-specific differences in conjunctival bacteria and evolution of antimicrobial resistance revealed by laboratory data surveillance |
| Q34371858 | Management of ophthalmic disease in general practice |
| Q34662722 | Management strategies for acute infective conjunctivitis in primary care: a systematic review |
| Q24188328 | Mast cell stabilisers for seasonal and perennial allergic conjunctivitis |
| Q24202609 | Mast cell stabilisers for seasonal and perennial allergic conjunctivitis |
| Q33702022 | Pattern of ophthalmological accidents and emergencies presenting to hospitals |
| Q44638481 | Present and future of the undergraduate ophthalmology curriculum: a survey of UK medical schools |
| Q35087095 | Primary care and ophthalmology in the United Kingdom |
| Q37133734 | Red eyes and red-flags: improving ophthalmic assessment and referral in primary care |
| Q37763573 | Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary |
| Q35599079 | The accuracy of the Edinburgh Red Eye Diagnostic Algorithm |
| Q38190827 | The role of besifloxacin in the treatment of bacterial conjunctivitis |
| Q39747466 | The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis |
| Q35040175 | The treatment of acute infectious conjunctivitis with fusidic acid: a randomised controlled trial |
| Q34220365 | Topical antibiotics for acute bacterial conjunctivitis: a systematic review. |
| Q24200402 | Topical cyclosporine for atopic keratoconjunctivitis |
| Q24236591 | Topical cyclosporine for atopic keratoconjunctivitis |
| Q57470390 | Toxic epidermal necrolysis: the red eye and red herrings in casualty |
| Q35155277 | Urgent Eye Care in the UK Increased Demand and Challenges for the Future |
| Q36896083 | Why are new patients coming to the eye clinic? An analysis of the relative frequencies of ophthalmic disease amongst new patients attending hospital eye clinics in two separate locations. |
Search more.